Endotoxin recognition molecules, Toll-like receptor 4-MD-2

Seminars in Immunology

Volumn 16, Issue 1, 2004, Pages 11-16

  Miyake, Kensuke ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

MD 1; MD 2; Radioprotective 105 (RP105); Toll like receptor (TLR)

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; ENDOTOXIN RECOGNITION MOLECULE; LIGAND; LIPOPOLYSACCHARIDE BINDING PROTEIN; MEMBRANE PROTEIN; PROTEIN; PROTEIN MD 1; PROTEIN MD 2; RADIOPROTECTIVE 105; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

B LYMPHOCYTE; BACTERIAL INFECTION; CELL SURFACE; GRAM NEGATIVE BACTERIUM; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSTIMULATION; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 0742324858     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2003.10.007     Document Type: Article

References (57)

1. Janeway C.A. Jr., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20:2002;197-216.
2. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
3. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
4. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K.et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1999;1777-1782.
5. Kitchens R.L., Wang P.-Y., Munford R.S. Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. J. Immunol. 161:1998;5534-5545.
6. Tobias P.S., Soldau K., Gegner J.A., Mintz D., Ulevitch R.J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:1995;10482-10488.
7. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C.et al. Structure and function of lipopolysaccharide binding protein. Science. 249:1990;1429-1431.
8. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J.et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity. 4:1996;407-414.
9. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
10. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J., Gros P.et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:1999;615-625.
11. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y.et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
12. O'Neill L.A., Dinarello C.A. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today. 21:2000;206-209.
13. Miyake K., Yamashita Y., Ogata M., Sudo T., Kimoto M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154:1995;3333-3340.
14. Miyake K., Shimazu R., Kondo J., Niki T., Akashi S., Ogata H.et al. Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J. Immunol. 161:1998;1348-1353.
15. Miyake K., Yamashita Y., Hitoshi Y., Takatsu K., Kimoto M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kDa molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180:1994;1217-1224.
16. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer From CD14 to TLR4 and MD-2. J. Biol. Chem. 276:2001;21129-21135.
17. Ohnishi T., Muroi M., Tanamoto K. N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide. J. Immunol. 167:2001;3354-3359.
18. Schromm A.B., Lien E., Henneke P., Chow J.C., Yoshimura A., Heine H.et al. Molecular genetic analysis of an endotoxin non-responder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194:2001;79-88.
19. Visintin A., Mazzoni A., Spitzer J.A., Segal D.M. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc. Natl. Acad. Sci. U.S.A. 98:2001;12156-12161.
20. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S.et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3:2002;667-672.
21. Re F., Strominger J.L. Monomeric recombinant MD-2 binds Toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness. J. Biol. Chem. 277:2002;23427-23432.
22. Mullen G.E., Kennedy M.N., Visintin A., Mazzoni A., Leifer C.A., Davies D.R.et al. The role of disulfide bonds in the assembly and function of MD-2. Proc. Natl. Acad. Sci. U.S.A. 100:2003;3919-3924.
23. da Silva Correia J., Ulevitch R.J. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277:2002;1845-1854.
24. Kato K., Morrison A.M., Nakano T., Tashiro K., Honjo T. ESOP-1, a secreted protein expressed in the hematopoietic, nervous, and reproductive systems of embryonic and adult mice. Blood. 96:2000;362-364.
25. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168:2002;554-561.
26. Nagai Y., Shimazu R., Ogata H., Akashi S., Sudo K., Yamasaki H.et al. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood. 99:2002;1699-1705.
27. Ohnishi T., Muroi M., Tanamoto K. MD-2 is necessary for the Toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface. Clin. Diagn. Lab. Immunol. 10:2003;405-410.
28. Muroi M., Ohnishi T., Tanamoto K. Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B. J. Biol. Chem. 277:2002;42372-42379.
29. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell. Sci. 115:2002;2603-2611.
30. Viriyakosol S., Tobias P.S., Kitchens R.L., Kirkland T.N. MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276:2001;38044-38051.
31. Mancek M., Pristovsek P., Jerala R. Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein. Biochem. Biophys. Res. Commun. 292:2002;880-885.
32. Poltorak A., Ricciardi-Castagnoli P., Citterio S., Beutler B. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2163-2167.
33. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K.et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:2000;497-504.
34. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:2002;354-359.
35. Rassa J.C., Meyers J.L., Zhang Y., Kudaravalli R., Ross S.R. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. U.S.A. 99:2002;2281-2286.
36. Kawasaki K., Akashi S., Shimazu R., Yoshida T., Miyake K., Nishijima M. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol. J. Endotoxin Res. 7:2001;232-236.
37. Guillot L., Balloy V., McCormack F.X., Golenbock D.T., Chignard M., Si-Tahar M. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:2002;5989-5992.
38. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O.et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 298:2002;1025-1029.
39. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D., Wagner H. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277:2002;15107-15112.
40. Ohashi K., Burkart V., Flohe S., Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164:2000;558-561.
41. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J.et al. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:2001;10229-10233.
42. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276:2001;16683-16689.
43. Bochkov V.N., Kadl A., Huber J., Gruber F., Binder B.R., Leitinger N. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature. 419:2002;77-81.
44. Miller Y.I., Viriyakosol S., Binder C.J., Feramisco J.R., Kirkland T.N., Witztum J.L. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J. Biol. Chem. 278:2003;1561-1568.
45. Kiechl S., Lorenz E., Reindl M., Wiedermann C.J., Oberhollenzer F., Bonora E.et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 347:2002;185-192.
46. O'Brien A.D., Rosenstreich D.L., Scher I., Campbell G.H., MacDermott R.P., Formal S.B. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J. Immunol. 124:1980;20-24.
47. Woods J.P., Frelinger J.A., Warrack G., Cannon J.G. Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect. Immun. 56:1988;1950-1955.
48. Gebran S.J., Yamamoto Y., Newton C., Tomioka M., Widen R., Klein T.W.et al. LPS inhibits the intracellular growth of Legionella pneumophila in thioglycolate elicited murine peritoneal macrophages by iron-dependent, tryptophan-independent, oxygen-independent, and arginine-independent mechanisms. J. Leukoc. Biol. 57:1995;80-87.
49. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E.et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of Gram-negative infections. J. Infect. Dis. 186:2002;1522-1525.
50. Jude B.A., Pobezinskaya Y., Bishop J., Parke S., Medzhitov R.M., Chervonsky A.V.et al. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4:2003;573-578.
51. Chan V.W., Mecklenbrauker I., Su I., Texido G., Leitges M., Carsetti R. et al. The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J. Exp. Med. 188:1998;93-101.
52. Ogata H., Su I.-H., Miyake K., Nagai Y., Akashi S., Mecklenbrauker I.et al. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192:2000;23-30.
53. Nagai Y., Shimazu R., Ogata H., Akashi S., Sudo K., Yamasaki H.et al. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood. 99:2002;1699-1705.
54. Yazawa N., Fujimoto M., Sato S., Miyake K., Asano N., Nagai Y.et al. CD19 regulates innate immunity by the Toll-like receptor RP105 signaling in B lymphocytes. Blood. 102:2003;1374-1380.
55. Kawasaki K., Akashi S., Shimazu R., Yoshida T., Miyake K., Nishijima M. Mouse toll-like receptor 4. MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J. Biol. Chem. 275:2000;2251-2254.
56. Means T.K., Jones B.W., Schromm A.B., Shurtleff B.A., Smith J.A., Keane J.et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol. 166:2001;4074-4082.
57. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A.et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:2000;398-401.